The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Clinical study on mechanism of treating ischemic heart diease with Xinnao Tongluo Liquid
Author(s): 
Pages: 22-24
Year: Issue:  6
Journal: ACTA CHINESE MEDICINE AND PHARMACOLOGY

Keyword:  缺血性心脏病心脑通络液临床研究;
Abstract: 目的:探讨心脑通络液治疗缺血性心脏病的机理.方法:本研究选择60例缺血性心脏病患者,随机分为两组,对30例患者在常规西药基础上加心脑通络液进行治疗,并与30例常规西药基础上加地奥心血康进行4W治疗,对比观察.结果:治疗组在改善临床症状,调节血脂代谢,增强外周血超氧化物歧化酶(SOD)活性,降低丙二醛(MDA)水平方面疗效优于对照组(P<0.05).结论:心脑通络液具有调节血脂代谢,增强外周血超氧化物歧化酶(SOD)活性,降低丙二醛(MDA),保护缺血心肌,改善心脏功能的作用.
Related Articles
No related articles found